Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-17-000002

CEO acquired 29,475 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BUNKA CHRISTOPHER CEO 2017-12-01 Grant or award +29,475 $0.82 $24,170 7,265,054 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…